NCT07048847Completed
The Effect of Aerobic Exercise on Selective Biomarkers of Patients With Cancer
The Effect of Supervised Aerobic Exercise on Adipokine and Myokine Biomarkers in Patients With Cancer During Systemic Chemotherapy
Source: ClinicalTrials.gov · Last updated 3 Jul 2025
Brief summary (registry, in English)
This study is a single-blinded, prospective, controlled trial aiming to evaluate the effect of supervised aerobic exercise on adipokine and myokine biomarkers in patients with breast or colon cancer during their systemic chemotherapy.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 32 (actual)
- First submitted
- 10 Jun 2025
- Start date
- 15 Sept 2022
- Primary completion date
- 15 Aug 2023
- Lead sponsor
- Izmir Bakircay University
- Diseases
- Colorectal cancer
- NCT number
- NCT07048847
What you commit to
- Study type: Observational
- Participants enrolled: 32
- From 15 Sept 2022 to the primary completion date, 15 Aug 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Ongoing medical and/or surgical (if any) complications
Other illness
- Having any condition which corresponds to the contraindication of exercise (i.e. advanced stages, distant metastasis, infection)
Other
- Having 2 or above grades according to the Eastern Cooperative Oncology Group (ECOG) performance status
- Having mental and/or cognitive deficits
- Having neurological/orthopedical and/or severe respiratory dysfunctions
- Having unstable vital parameters or having regularly used pharmacological interventions
Who the study is looking for
- Having been diagnosed with solid type of cancer
- Being candidate for systemic chemotherapy
- Being volunteer to participate in an exercise program
- Aged between 18-70 years old
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bakircay University Çiğli State and Training Hospital, Department of Medical Oncology Coordinator of this site? Confirm its status | Izmir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.